Leather, David A. http://orcid.org/0000-0002-5871-0975
Yates, Louisa
Svedsater, Henrik
Jacques, Loretta
Collier, Susan
Powell, Danielle
Jones, Rupert
Funding for this research was provided by:
GlaxoSmithKline plc (N/A)
Article History
Received: 14 January 2019
Accepted: 8 July 2019
First Online: 2 August 2019
Ethics approval and consent to participate
: The Salford Lung Study protocols were approved by the National Research Ethics Service Committee North West, Greater Manchester South (approval numbers 12/NW/0455 and 11/NW/0798). All patients provided written informed consent for participation.
: All authors have contributed to the writing and/or critical review of this manuscript and all have approved the final version for submission for publication.
: DAL, LY, HS, LJ, SC, and DP disclose employment with, and stock/share ownership in, GlaxoSmithKline plc. RJ has received grants from AstraZeneca and GlaxoSmithKline plc., and personal fees from AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline plc., Novartis, Nutricia and Pfizer outside the submitted work.